BR0208005A - Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo - Google Patents

Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo

Info

Publication number
BR0208005A
BR0208005A BR0208005-2A BR0208005A BR0208005A BR 0208005 A BR0208005 A BR 0208005A BR 0208005 A BR0208005 A BR 0208005A BR 0208005 A BR0208005 A BR 0208005A
Authority
BR
Brazil
Prior art keywords
delayed type
type hypersensitivity
inducer
present
topical
Prior art date
Application number
BR0208005-2A
Other languages
English (en)
Inventor
Jutaro Shudo
Ichiro Mori
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of BR0208005A publication Critical patent/BR0208005A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • A61F13/0276Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PREPARAçãO PARA ADESIVO TóPICO CONTENDO INDUTOR DE HIPERSENSIBILIDADE DO TIPO RETARDADO E PROCESSOS PARA A UTILIZAçãO DO MESMO". A invenção refere-se à preparações para adesivos tópicos que contêm um indutor de hipersensibilidade do tipo retardado, por exemplo, 1-dicloro-2,4-dinitrobenzeno (DNCB) e processos para a utilização dos mesmos. As presentes preparações para adesivos tópicos são constituídas de uma composição de gel adesivo que está presente sobre um suporte, em que a composição de gel adesivo inclui o indutor de hipersensibilidade do tipo retardado, um gel de polímero solúvel em água, água e um agente de sustentação de água. Utilizando as presentes preparações para adesivos tópicos, as preparações para adesivos tópicos são aplicadas sobre uma superfície da pele de um indivíduo e são mantidas no local de aplicação durante um período de tempo suficiente para que uma quantidade eficaz do indutor de hipersensibilidade do tipo retardado seja administrada ao indivíduo, onde este período de manutenção tipicamente não excede aproximadamente 60 minutos. A presente invenção encontra uso em uma variedade de aplicações onde a administração de um indutor de hipersensibilidade do tipo retardado é desejada e é particularmente adequada para uso no tratamento de condições de doença associadas com o HIV, por exemplo, a AIDS.
BR0208005-2A 2001-03-12 2002-02-22 Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo BR0208005A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27521301P 2001-03-12 2001-03-12
PCT/US2002/005641 WO2002072081A1 (en) 2001-03-12 2002-02-22 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Publications (1)

Publication Number Publication Date
BR0208005A true BR0208005A (pt) 2004-03-02

Family

ID=23051331

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208005-2A BR0208005A (pt) 2001-03-12 2002-02-22 Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo

Country Status (22)

Country Link
US (3) US6761900B2 (pt)
EP (1) EP1370251A1 (pt)
JP (2) JP2004524327A (pt)
KR (2) KR20090117839A (pt)
CN (1) CN100594893C (pt)
AU (1) AU2002247209C1 (pt)
BR (1) BR0208005A (pt)
CA (1) CA2440209A1 (pt)
CR (1) CR7078A (pt)
EA (1) EA006208B1 (pt)
HK (1) HK1072364A1 (pt)
IL (2) IL157795A0 (pt)
ME (1) MEP9808A (pt)
MX (1) MXPA03008206A (pt)
NO (1) NO20033985L (pt)
NZ (1) NZ528098A (pt)
PL (1) PL363839A1 (pt)
RS (1) RS50729B (pt)
TW (1) TWI331521B (pt)
UA (1) UA79587C2 (pt)
WO (1) WO2002072081A1 (pt)
ZA (1) ZA200306997B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
US7645916B2 (en) * 2003-01-23 2010-01-12 Specialty Silicone Fabricators, Inc. Elastically deformable fabric with gel coated surface
US20040147187A1 (en) * 2003-01-23 2004-07-29 Rasor Allen C. Elastically deformable fabric with gel coated surface
ITMI20030414A1 (it) * 2003-03-06 2004-09-07 Biofarm S R L Ora Biofarmitalia S P A Tampone con strato di gel con attivita' cosmetica o terapeutica.
US20060211766A1 (en) * 2004-09-30 2006-09-21 Kaplan Leonard L Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
AP2007003963A0 (en) * 2004-09-30 2007-04-30 Teikoku Pharma Usa Inc 1-Chloro-2,4-dinitrobenzene gel compositions and methods for using the same
AU2005323206C1 (en) * 2005-01-04 2010-01-07 Teikoku Pharma Usa, Inc. Cooling topical patch preparation
EP1940377A4 (en) * 2005-10-24 2010-12-08 Teikoku Pharma Usa Inc TOPICAL AEROSPECTIVE COMPOSITIONS OF N, 2,3-TRIMETHYL-2-ISOPROPYLBUTAMIDE AND METHOD OF USE THEREOF
JP5010829B2 (ja) * 2005-12-28 2012-08-29 帝國製薬株式会社 貼付剤
JP5010834B2 (ja) * 2006-02-20 2012-08-29 帝國製薬株式会社 貼付剤
KR101352238B1 (ko) 2007-04-04 2014-01-15 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 단순포진바이러스 감염 치료를 위한 비특이적 지연형 과민증 반응
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
EP3494790A1 (en) 2010-03-02 2019-06-12 Phio Pharmaceuticals Corp. Effective sensitizing dose of a gelled immunomodulating topical composition
EP3087985B1 (en) * 2013-12-18 2018-10-17 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
US20160279083A1 (en) * 2015-02-24 2016-09-29 Moein Health, Inc. Topical treatment for cervical intraepithelial neoplasia
US10588564B2 (en) 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
EP3261654B1 (en) 2015-02-26 2021-08-11 Squarex, LLC Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
KR101646181B1 (ko) 2015-08-18 2016-08-05 한양대학교 에리카산학협력단 이리노테칸 함유 이중역상 온도감응성 수용성 겔 조성물
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR20170099737A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 이를 이용하는 염색 방법
BR112021011103A8 (pt) * 2018-12-18 2022-08-09 Currahee Holding Company Inc Emplastro personalizado para aplicação tópica
CN112315661A (zh) * 2020-10-26 2021-02-05 广东泰宝医疗科技股份有限公司 一种持效期长的离子感应贴

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2375861A1 (fr) 1976-12-31 1978-07-28 Merieux Inst Tampon adhesif pour tests epicutanes
US4129547A (en) * 1977-06-30 1978-12-12 E. I. Du Pont De Nemours And Company High solids coating compositions for flexible substrates containing urea-formaldehyde
US4129647A (en) 1977-10-17 1978-12-12 Edmund Klein Treatment of acne
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
DE69524614T2 (de) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy
JPH11171768A (ja) 1997-10-15 1999-06-29 Taisho Pharmaceut Co Ltd 消炎鎮痛外用剤
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Also Published As

Publication number Publication date
NZ528098A (en) 2004-04-30
KR20030088457A (ko) 2003-11-19
UA79587C2 (en) 2007-07-10
JP2004524327A (ja) 2004-08-12
RS50729B (sr) 2010-08-31
JP2010013474A (ja) 2010-01-21
MXPA03008206A (es) 2004-11-12
CN100594893C (zh) 2010-03-24
US20040219200A1 (en) 2004-11-04
IL157795A0 (en) 2004-03-28
TWI331521B (en) 2010-10-11
MEP9808A (en) 2010-06-10
CR7078A (es) 2004-03-10
EA200300995A1 (ru) 2004-02-26
KR20090117839A (ko) 2009-11-12
CN1561202A (zh) 2005-01-05
WO2002072081A1 (en) 2002-09-19
HK1072364A1 (en) 2005-08-26
EP1370251A1 (en) 2003-12-17
NO20033985D0 (no) 2003-09-09
CA2440209A1 (en) 2002-09-19
IL157795A (en) 2007-08-19
AU2002247209B2 (en) 2005-11-17
ZA200306997B (en) 2004-09-08
PL363839A1 (en) 2004-11-29
US6761900B2 (en) 2004-07-13
NO20033985L (no) 2003-11-03
US20040219199A1 (en) 2004-11-04
US20020176886A1 (en) 2002-11-28
EA006208B1 (ru) 2005-10-27
AU2002247209C1 (en) 2006-08-10
YU70703A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
BR0208005A (pt) Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
BR9806470B1 (pt) preparação do tipo absorção percutánea.
TW200637529A (en) Topical patch cooling preparation and methods for using the same
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
JP2004505007A5 (pt)
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0214344A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DK1009393T3 (da) Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
WO2004078122A3 (en) Invisible patch for active agnet controlled delivery
CO4410203A1 (es) Formulaciones de analogos de insulina
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
BR0317177A (pt) Preparações de liberação controlada compreendendo tramadol e topiramato
JP2004524327A5 (pt)
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
BR9904613A (pt) Utilização de uma goma de silicone, composição tópica e utilização de uma composição
BR9813514A (pt) Agente para tratamento de fibras queratìnicas
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BR0316463A (pt) Administração dérmica de um inibidor seletivo de ciclooxigenase-2 solúvel em água, por exemplo, derivados de parecoxib, valdecoxib e benzopirano
BR0008192A (pt) Emplastros tipo folha

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]